Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-16T05:21:28.620Z Has data issue: false hasContentIssue false

Droperidol and dimenhydrinate alone or in combination for the prevention of post-operative nausea and vomiting after nasal surgery in male patients

Published online by Cambridge University Press:  16 August 2006

L. H. J. Eberhart
Affiliation:
Department of Anaesthesiology, University of Ulm, D-89070 Ulm, Germany
W. Seeling
Affiliation:
Department of Anaesthesiology, University of Ulm, D-89070 Ulm, Germany
T. Hartschuh
Affiliation:
Department of Anaesthesiology, University of Ulm, D-89070 Ulm, Germany
A. M. Morin
Affiliation:
Department of Anaesthesiology, University of Ulm, D-89070 Ulm, Germany
M. Georgieff
Affiliation:
Department of Anaesthesiology, University of Ulm, D-89070 Ulm, Germany
Get access

Abstract

Droperidol and dimenhydrinate are inexpensive anti-emetic drugs. Droperidol, especially, has been studied extensively, but there are no studies on the combination of both drugs for prevention of post-operative nausea and vomiting. One hundred and forty male hospitalized patients undergoing nasal surgery were randomized to receive one of four anti-emetic regimes: placebo, dimenhydrinate (1 mg kg−1), droperidol (15 μg kg−1), or the combination of both drugs (droperidol 15 μg kg−1+dimenhydrinate 1 mg kg−1) administered after induction of anaesthesia. Patients in the dimenhydrinate-group and the combination-group received a second dose of dimenhydrinate 6 h after the first administration to mitigate the short half-life of the drug. For general anaesthesia a standardized technique, including benzodiazepine premedication, propofol, desflurane in N2O/O2, vecuronium, and a continuous infusion of remifentanil, was used. Post-operative analgesia and anti-emetic rescue medication were standardized. Episodes of vomiting, retching, nausea, and the need for additional anti-emetics were recorded for 24 h. The main endpoint of this study was the number of patients who were completely free of post-operative nausea and vomiting (Fisher's Exact Test) Furthermore, the severity of post-operative nausea and vomiting was analysed using a standardized scoring algorithm. The incidence of patients completely free of post-operative nausea and vomiting was 62.9% in the placebo-group, 77.1% in the dimenhydrinate-group (P =0.21), and 82.9% in the droperidol-group (P =0.07). This increased to 94.3% in the combination-group (P =0.0015). In all three treatment groups the severity of post-operative nausea and vomiting was reduced significantly compared with placebo treatment (P =0.0003). The incidence of side effects was similar in the four groups. Dimenhydrinate was ineffective in reducing the incidence of post-operative nausea and vomiting and droperidol only reduced the severity of post-operative nausea and vomiting. However, the combination of both drugs significantly reduces the incidence of post-operative nausea and vomiting when compared with placebo treatment.

Type
Original Article
Copyright
1999 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)